Dysfunction of the autophagy-lysosomal pathway (ALP) and the ubiquitin-proteasome system (UPS) was thought to be an important pathogenic mechanism in synuclein pathology and Parkinson's disease (PD). In the present study, we investigated the role of sestrin2 in autophagic degradation of ␣-synuclein and preservation of cell viability in a rotenone-induced cellular model of PD. We speculated that AMP-activated protein kinase (AMPK) was involved in regulation of autophagy and protection of dopaminergic cells against rotenone toxicity by sestrin2. The results showed that both the mRNA and protein levels of sestrin2 were increased in a TP53-dependent manner in Mes 23.5 cells after treatment with rotenone. Genetic knockdown of sestrin2 compromised the autophagy induction in response to rotenone, while overexpression of sestrin2 increased the basal autophagy activity. Sestrin2 presumably enhanced autophagy in an AMPK-dependent fashion, as sestrin2 overexpression activated AMPK, and genetic knockdown of AMPK abrogated autophagy induction by rotenone. Restoration of AMPK activity by metformin after sestrin2 knockdown recovered the autophagy activity. Sestrin2 overexpression ameliorated ␣-synuclein accumulation, inhibited caspase 3 activation, and reduced the cytotoxicity of rotenone. These results suggest that sestrin2 upregulation attempts to maintain autophagy activity and suppress rotenone cytotoxicity through activation of AMPK, and that sestrin2 exerts a protective effect on dopaminergic cells.
Parkinson's disease (PD) is one of the most common neurodegenerative diseases in the aging population. The main pathological feature of PD is the degeneration of midbrain dopaminergic neurons located in the substantia nigra with the presence of ubiquitinated cytoplasmic inclusions, named Lewy bodies (LB), in the affected brain regions (1, 2). In vivo and in vitro genetic models overexpressing ␣-synuclein replicate the essential pathological features of PD (3, 4). ␣-Synuclein is an aggregate-prone protein, which, in pathological status, forms dimeric and higherorder toxic oligomeric species, which then serve as nuclei for the formation of protein aggregates, leading to dysfunction and degeneration of dopaminergic neurons (2, 5, 6).Autophagy, a conserved degradation pathway for proteins, lipids, and cellular organelles, is dysregulated in PD (7). Autophagy is both induced and impaired in several genetic and chemical models of PD, leading to an accumulation of immature autophagic vesicles and ␣-synuclein (8, 9). Enhancement of autophagy with overexpression of beclin1 effectively reduced ␣-synuclein accumulation and ameliorated PD pathology in animal models (10). Meanwhile, deficiency in autophagy-related genes, such as atg7, caused PD-like neurodegeneration (11). Thus, autophagy might be protective in response to an increased burden of misfolded protein and/or chemical intoxication (8,(12)(13)(14)(15). In vivo study with CCI-779, a derivative of rapamycin, retarded the progression of ␣-synuclein-induced neurodegeneration by acti...